Literature DB >> 27870657

Health Care Utilization and Cost in Children and Adolescents With Chronic Pain: Analysis of Health Care Claims Data 1 Year Before and After Intensive Interdisciplinary Pain Treatment.

Ann-Kristin Ruhe1, Michael Frosch, Julia Wager, Roland Linder, Ingo Pfenning, Dirk Sauerland, Boris Zernikow.   

Abstract

OBJECTIVES: The aim of this study was to analyze changes in health care utilization and cost among a sample of highly impaired children and adolescents who sought a 3-week intensive interdisciplinary pain treatment (IIPT).
MATERIALS AND METHODS: Claims data from 7 statutory health insurance companies were analyzed for 65 children and adolescents who sought IIPT at the German Paediatric Pain Centre. The annual health care utilization and cost were determined for the following 4 areas: outpatient care, inpatient care, medications, and remedies and aids. We analyzed the changes in resource utilization in the year before (pre_1 y) IIPT and in the subsequent year (post_1 y).
RESULTS: Within the first year after IIPT, overall health care costs did not decrease significantly. However, the pattern of health care utilization changed. First, significantly more children and adolescents started outpatient psychotherapy (P=0.001). Second, the number of hospitalized children decreased significantly from 1-year pre to 1-year post (P=0.001). Accordingly, there were significantly fewer hospitalizations for primary chronic pain disorders at 1-year post (P<0.001). The prescription of nonopioids, co-analgesics and opioids was significantly reduced from 1-year pre to 1-year post (all P<0.013). DISCUSSION: The present results indicate that the health care costs of children and adolescents with severe chronic pain disorders do not significantly decrease 1 year after IIPT; however, the treatment becomes more goal-focused. Differential diagnosis measures and nonindicated therapeutic interventions decreased, and more indicated interventions, such as psychotherapy, were used. Future research is needed to investigate the economic long-term changes after IIPT.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27870657     DOI: 10.1097/AJP.0000000000000460

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  4 in total

1.  Effect on Health Care Costs for Adolescents Receiving Adjunctive Internet-Delivered Cognitive-Behavioral Therapy: Results of a Randomized Controlled Trial.

Authors:  Emily F Law; Cornelius B Groenewald; Chuan Zhou; Tonya M Palermo
Journal:  J Pain       Date:  2018-03-22       Impact factor: 5.820

2.  Chronic pain-related consultations to the emergency department of children with complex pain conditions: A retrospective analysis of healthcare utilization and costs.

Authors:  Michelle Stoopler; Manon Choinière; Annabelle Nam; André Guigui; Laurel Walfish; Nada Mohamed; Marie Vigouroux; Victor-Hugo González-Cárdenas; Pablo Ingelmo
Journal:  Can J Pain       Date:  2022-06-17

3.  Lymphocyte opioid receptors as innovative biomarkers of osteoarthritic pain, for the assessment and risk management of opioid tailored therapy, before hip surgery, to prevent chronic pain and opioid tolerance/addiction development: OpMarkArt (Opioids-Markers-Arthroprosthesis) study protocol for a randomized controlled trial.

Authors:  Valentina Malafoglia; Monica Celi; Carolina Muscoli; Sara Ilari; Filomena Lauro; Luigino Antonio Giancotti; Chiara Morabito; Maurizio Feola; Umberto Tarantino; William Raffaeli
Journal:  Trials       Date:  2017-12-19       Impact factor: 2.279

4.  Multidisciplinary care for opioid dose reduction in patients with chronic non-cancer pain: A systematic realist review.

Authors:  Abhimanyu Sud; Alana Armas; Heather Cunningham; Shawn Tracy; Kirk Foat; Navindra Persaud; Fardous Hosseiny; Sylvia Hyland; Leyna Lowe; Erin Zlahtic; Rhea Murti; Hannah Derue; Ilana Birnbaum; Katija Bonin; Ross Upshur; Michelle L A Nelson
Journal:  PLoS One       Date:  2020-07-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.